Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Diabetes Management During the Covid-19 Pandemic: An Iranian Expert Opinion Statement Publisher Pubmed



Malek M1 ; Hosseinpanah F2 ; Meybodi HRA3 ; Jahed SA4 ; Hadaegh F5 ; Sharghi S3 ; Esteghamati A6 ; Khamseh ME7
Authors

Source: Archives of Iranian Medicine Published:2020


Abstract

The coronavirus infection is an evolving pandemic with high morbidity and mortality, especially in people with comorbidities. The case fatality rate (CFR) is 9.2% in the presence of diabetes, while it is 1.4% in those without any comorbidity. Diabetes is a prevalent disease globally; hence, healthcare professionals are highly concerned about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic progression. Current evidence does not support higher incidence of coronavirus disease 2019 (COVID-19) in people with diabetes (PWD). However, people with diabetes are considered high risk for developing complications. Optimal metabolic control is a challenging concept, especially in the presence of an acute and severe respiratory viral infection. In this consensus, we considered the challenging issues in management of patients with diabetes during the COVID-19 pandemic. The consensus covers various aspects of outpatient as well as inpatient care based on the current evidence. © 2020 The Author(s).
Other Related Docs
6. Covid-19 in Patients With Diabetes: Factors Associated With Worse Outcomes, Journal of Diabetes and Metabolic Disorders (2021)
14. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
16. Covid-19: Significance of Antibodies, Human Antibodies (2020)
19. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
20. A Late Covid-19 Complication: Male Sexual Dysfunction, Prehospital and Disaster Medicine (2020)